Phase Week 4-8 Window Reported changes What People Report Some users report changes in recovery, sleep quality, or skin
Stacking with GHRH (e.g., CJC-1295) To increase the amplitude and duration of GH release, many users stack Ipamorelin with a growth hormone-releasing hormone (GHRH) like CJC-1295 without DAC
Potential Risks, Side Effects and Safety Concerns Risks include water retention, elevated IGF-1, impaired glucose tolerance, and injection site infection for CJC 1295 and ipamorelin
Dumestre-Toulet, V., Cirimele, V., Ludes, B., Gromb, S
A clear solution tells you nothing about whether the amino acid sequence remains intact
Variety of appointment times available